@Steini CDH17 has nothing to do with IMU, I can see the correlation but I'm not sure why IMU keeps getting brought up . CHM17 trial has been set up as a Phase 1/2 trial and estimated completion date 2 years from it's mid-year start. Pending data, accelerated approval is a possibility for several different cancer types with a very high unmet need.
Some of the recent acquisition's I've seen have been prior to completion of phase 1/2 trials due to strong data. Big Pharma are sitting on 3/4 of a trillion $$ and they are about to fall off a patent cliff. If CHM 2101 can back up what it did pre-clinic, we'll have some of the hottest property in all of oncology.
I can sympathise with those who bought in early but no one is more underwater than PH himself. Whether or not he gets involved in the 800 million placement is yet to be seen but common sense says he eventually wants the SP much much higher than it current is.
- Forums
- ASX - By Stock
- Ann: Notice of Extraordinary General Meeting/Proxy Form
@Steini CDH17 has nothing to do with IMU, I can see the...
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
-0.002(10.0%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $94.72K | 5.176M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1336845 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 700678 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1336845 | 0.018 |
9 | 945219 | 0.017 |
6 | 652631 | 0.016 |
8 | 1276836 | 0.015 |
4 | 2549999 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 700678 | 5 |
0.020 | 178304 | 1 |
0.021 | 339793 | 2 |
0.022 | 200000 | 1 |
0.023 | 724246 | 3 |
Last trade - 14.22pm 30/05/2024 (20 minute delay) ? |
|
|||||
Last
1.9¢ |
  |
Change
-0.002 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
1.8¢ | 2.0¢ | 1.8¢ | 3211515 | ||
Last updated 13.59pm 30/05/2024 ? |
Featured News
CHM (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin & Ramón Jiménez Serrano, Managing Director & Executive Director
Ryan Parkin & Ramón Jiménez Serrano
Managing Director & Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online